Sármellék (HU)
{name}
{subtitle}
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)
city
~24 mi. (Zalaegerszeg, Hungary, +140 more cities)
facility
Zala Megyei Szent Rafael Korhaz ( Site 0265)
condition
Hepatocellular Carcinoma
drug
lenvatinib, +2 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Olaparib (MK-7339) With or Without Bevacizumab Compared to Bevacizumab With a Fluoropyrimidine in Unresectable or Metastatic Colorectal Cancer (CRC) (MK-7339-003/LYNK-003)
city
~24 mi. (Zalaegerszeg, Hungary, +105 more cities)
facility
Zala Megyei Szent Rafael Korhaz ( Site 1429)
condition
Colorectal Adenocarcinoma
drug
bevacizumab, +1 more drug
drug type
targeted therapy
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~51 mi. (Kaposvár, Hungary, +199 more cities)
facility
Somogy Megyei Kaposi Mór Oktató Kórház-Oncology center ( Site 0484)
condition
Hepatocellular Carcinoma
drug
pembrolizumab
drug type
immunotherapy
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
city
~51 mi. (Kaposvár, Hungary, +201 more cities)
facility
Somogy Megyei Kaposi Mor Oktato Korhaz /ID# 221703
condition
Myelodysplastic Syndromes
drug
azacitidine, +1 more drug
drug type
chemotherapy
A Study of Oral Venetoclax Tablets and Oral Azacitidine Versus Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy
city
~51 mi. (Kaposvár, Hungary, +197 more cities)
facility
Somogy Megyei Kaposi Mor Oktato Korhaz /ID# 214426
biomarker
BCR-ABL1 Fusion, +47 more biomarkers
condition
Acute Myeloid Leukemia
drug
azacitidine, +1 more drug
drug type
chemotherapy
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
city
~51 mi. (Kaposvár, Hungary, +72 more cities)
facility
Somogy Megyei Kaposi Mór Oktató Kórház
biomarker
del(11)(q10), +27 more biomarkers
condition
Primary Myelofibrosis, +1 more condition
drug
navtemadlin
drug type
targeted therapy
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~54 mi. (Farkasgyepű, Hungary, +145 more cities)
facility
Veszprem Megyei Tudogyogyintezet ( Site 2313)
condition
Non-Small Cell Lung Carcinoma
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012)
city
~59 mi. (Szombathely, Hungary, +144 more cities)
facility
Markusovszky Egyetemi Oktatokorhaz ( Site 2303)
condition
Clear Cell Renal Cell Carcinoma
drug
belzutifan, +3 more drugs
drug type
immunotherapy, +1 more type
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
city
~90 mi. (Pécs, Hungary, +130 more cities)
facility
Pécsi Tudományegyetem Klinikai Központ-Urológiai Klinika ( Site 1304)
condition
Bladder Urothelial Carcinoma
drug
BCG solution, +1 more drug
drug type
immunotherapy